Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation

CorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030.

Subsidie
€ 2.500.000
2022

Projectdetails

Introduction

Electrical brain stimulation has been successfully used since the 1990s to treat neurological illnesses, particularly movement disorders. Most of the devices for this novel approach are based on the old pacemaker technology.

Challenges in Development

Companies are unwilling to take device development risks and rely on established technology, limiting new therapy developments. Many neurological diseases are still treated with pharmaceuticals only, which has limited effectiveness and causes severe side effects.

Advancements in Neuromodulation

Neuromodulation and electrical stimulation research has increased in recent decades. Additional recording capabilities and closed-loop therapy expand therapeutic options.

CorTec's Vision

CorTec aims to provide novel implantable technology to overcome the current limitations. This technology enables researchers, medical institutions, and industry to develop new therapies and devices.

Future Plans

We plan to finalize the development of our technology for stroke rehabilitation, conduct clinical trials, and obtain market approval in 2029, generating $250 million in sales by 2030.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.500.000
Totale projectbegroting€ 3.675.427

Tijdlijn

Startdatum1-11-2022
Einddatum31-10-2024
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • CORTEC GMBHpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

A new cardioprotective drug for acute treatment of myocardial infarction

ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.

€ 2.499.999
EIC Accelerator

Clear, scalable and scientific framework to measure terrestrial biodiversity

3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.

€ 2.252.714
EIC Accelerator

Novel and Scalable microbial products for REgenerative agriculture

N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.

€ 2.499.999
EIC Accelerator

Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security

Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.

€ 2.499.999

Vergelijkbare projecten uit andere regelingen

EIC Transition

BRAIN-SPINE INTERFACES TO REVERSE UPPER- AND LOWER-LIMB PARALYSIS

Developing fully-implantable brain-spine interfaces to restore movement in individuals with chronic paralysis through advanced neurosensors and neurostimulation systems.

€ 2.490.802
ERC POC

Deep Brain Neuromodulation using Temporal Interference Magnetic Stimulation

Develop a non-invasive tool using temporal interference magnetic stimulation for precise modulation of neural activity in the brain, aiming to improve treatment options for brain disorders.

€ 150.000
ERC COG

Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health

This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.

€ 1.999.875
EIC Pathfinder

Advanced Intelligent stimulation device: HAND movement restoration

The AI-HAND project aims to develop an advanced ASIC-based implanted device with self-adapting electrodes to restore hand movements in quadriplegic patients through innovative nerve stimulation techniques.

€ 2.999.834